BeyondSpring Inc.

BYSI Nasdaq SEC CIK 1677940
Follow BeyondSpring Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0
Net income $50.8M +3398.2% vs same quarter last year
EPS, diluted $1.24 +3200% vs same quarter last year
Operating cash flow −$3.6M +14.2% vs same quarter last year
Revenue by quarter
$0
$0
$0
$0
$0
$0
$0
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income13 fiscal years
  • Revenue
  • Net income
−$100M−$75M−$50M−$25M$0$25MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$0−$1M
FY24$0−$11.1M
FY23$0−$21M
FY22$1.4M−$33.3M
FY21$1.4M−$64.2M
FY20$180K−$61M
FY19$0−$38.1M
FY18$0−$54.9M
FY17$0−$91.8M
FY16$0−$12M
FY15$0−$8M
FY14$0−$3M
FY13--
MarginsShare of revenue
  • Operating margin
  • Net margin
−40000%−30000%−20000%−10000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24--
FY23--
FY22−2756.4%−2463.3%
FY21−4903%−4750.5%
FY20−35672.8%−33873.9%
FY19--
FY18--
FY17--
FY16--
FY15--
FY14--
FY13--
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$19.8M
FY24−$16.7M
FY23−$16.6M
FY22−$27.5M
FY21−$50.1M
FY20−$43.8M
FY19−$48.2M
FY18−$40.2M
FY17−$28.9M
FY16−$13.8M
FY15−$6.6M
FY14-
FY13-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • BeyondSpring
  • Healthcare median
−40000%−30000%−20000%−10000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBeyondSpringHealthcare median
FY25-−30.6%
FY24-−47%
FY23-−58%
FY22−2463.3%−80.4%
FY21−4750.5%−71.8%
FY20−33873.9%−62.2%
FY19-−46.2%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY15-−37.8%
FY14-−35.5%
FY13-−37.1%